Profound Medical Corp. (PRN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Perimeter Medical Imaging AI, Inc.

Nanalysis Scientific Corp.

Covalon Technologies Ltd.

Profound Medical Corp.

Theralase Technologies, Inc.

Spectral Medical, Inc.

MedMira, Inc.

Ocumetics Technology Corp.

FuelPositive Corp.

VentriPoint Diagnostics Ltd.

Opsens, Inc.

Why is Profound Medical Corp. ?

NET SALES(Q) At CAD 3.06 MM has Fallen at -25.91%
OPERATING CASH FLOW(Y) Lowest at CAD -48.56 MM
ROCE(HY) Lowest at -106.37%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -28.64%, its profits have fallen by -49.7%

Below par performance in long term as well as near term

Along with generating -28.64% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Profound Medical Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Profound Medical Corp.

-20.5%

-0.41

60.53%

S&P/TSX 60

19.1%

1.54

14.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.66%

EBIT Growth (5y)

-187.67%

EBIT to Interest (avg)

-38.21

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.82

Sales to Capital Employed (avg)

0.18

Tax Ratio

0.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

50.83%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.48

EV to EBIT

-3.36

EV to EBITDA

-3.41

EV to Capital Employed

16.54

EV to Sales

12.02

PEG Ratio

Dividend Yield

ROCE (Latest)

-491.65%

ROE (Latest)

-106.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET PROFIT(HY)

Higher at CAD -37.11 MM

RAW MATERIAL COST(Y)

Fallen by -15.23% (YoY

NET SALES(9M)

Higher at CAD 12.66 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 2.09%

-25What is not working for the Company

NET SALES(Q)

At CAD 3.06 MM has Fallen at -25.91%

OPERATING CASH FLOW(Y)

Lowest at CAD -48.56 MM

ROCE(HY)

Lowest at -106.37%

OPERATING PROFIT(Q)

Lowest at CAD -18.91 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -618.05 %

PRE-TAX PROFIT(Q)

Lowest at CAD -21.63 MM

NET PROFIT(Q)

Lowest at CAD -21.72 MM

EPS(Q)

Lowest at CAD -0.72

Here's what is working for Profound Medical Corp.

Debtors Turnover Ratio

Highest at 2.09%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -15.23% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Profound Medical Corp.

Net Sales

At CAD 3.06 MM has Fallen at -25.91%

over average net sales of the previous four periods of CAD 4.13 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CAD MM)

Pre-Tax Profit

At CAD -21.63 MM has Fallen at -94.22%

over average net sales of the previous four periods of CAD -11.14 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -21.72 MM has Fallen at -95.04%

over average net sales of the previous four periods of CAD -11.14 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Operating Cash Flow

Lowest at CAD -48.56 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Operating Profit

Lowest at CAD -18.91 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Operating Profit Margin

Lowest at -618.05 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CAD -21.63 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CAD MM)

Net Profit

Lowest at CAD -21.72 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)

EPS

Lowest at CAD -0.72

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CAD)